Advaxis Obtains $379,742 In Non-Dilutive Financing

Advaxis begins the year on a positive note in terms of financing. It was on the receiving end of $379,742 worth of funding from the financing program sponsored by the New Jersey Economic Development Authority (NJEDA).

The biotechnology company’s Chairman/CEO Thomas A. Moore shares that funding will be used for further clinical research. Here’s some more words from him in our recent e-interview:

Read More